Posted by Michael Wonder on 23 Jan 2020
The intricacies of rising drug prices in the US
23 January 2020 - Following 250 US drug price increases in 2020 already, this article explores why costs are rising, what changes could ensure brand reputations remain intact and what manufacturers can do to ensure they get their share.
With over 250 individual US drug price increases reported in 2020 already, Drug Target Review’s Hannah Balfour investigated the underlying issues behind these so-called ‘price-hikes’ and reported on what reforms could be instated to ensure brand reputations stay intact and manufacturers get paid.
